Global Tissue Banking Market, By Product (Equipment, Media and Consumables), Tissue Type (Heart Valves, Cornea, Bone, Skin, Brain and Spinal Cord), Application (Therapeutic, Cosmetic, Research and Development, Drug Discovery) – Industry Trends and Forecast to 2029.
Tissue Banking Market Analysis and Size
The tissue banking market is growing during the forecast period of 2022-2029. The growing elderly population, as well as the increased incidence of cardiovascular disease, cancer, diabetes, and other lifestyle disorders, are both contributing to the growth of the worldwide tissue banking market.
Data Bridge Market Research analyses that the tissue banking market which was USD 1.46 billion in 2021, would rocket up to USD 3.34 billion by 2029, and is expected to undergo a CAGR of 10.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Equipment, Media, and Consumables), Tissue Type (Heart Valves, Cornea, Bone, Skin, Brain and Spinal Cord), Application (Therapeutic, Cosmetic, Research and Development, Drug Discovery)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), Sigma-Aldrich Co. (U.S.), BioLifeSolutions (U.S.), Lifeline Scientific (U.S.), BioCision, Cesca Therapeutics, Inc. (U.S.), core dynamics GmbH (U.S.), Custom Biogenic Systems (U.S.), Atlanta Biologics Pvt. Ltd. (U.S.), Taylor-Wharton (U.S.), Panasonic Holdings Corporation (Japan), QIAGEN (Germany), VWR International, LLC (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The procedure of gathering, processing, and conserving transplantable human tissues for possible therapeutic purposes is referred to as tissue banking. The tissues recovered are used to repair and replace the patients' damaged or missing tissues. Injuries to the spinal cord, damaged heart muscles, and skin from severe burns can all be treated with them. The need for tissue banking and preservation is currently being driven by developments in biomedical research and clinical trials.
Tissue Banking Market Dynamics
Drivers
- Rising aging population
Additionally, the utilization of human tissue allografts is expanding globally because of an aging population and an increased number of people having surgical procedures. These tissues are utilized to restore limb function, lessen pain, and enhance the quality of life for patients. Additionally, the industry is being driven by the new trend of cosmetic surgery as a result of rising disposable income and rising body consciousness among people.
- Rise in chronic diseases
Growing chronic illness prevalence, rising healthcare spending on developing new pharmaceuticals, and expanding tissue engineering technology are some of the main drivers of the tissue banking market. According to recent data released by the WHO, chronic diseases are one of the world's biggest problems, and they are responsible for roughly 60% of all fatalities globally. The market is expanding as a result of developing clinical studies, rising organ donation and storage, and developments in the biopharmaceutical sector.
Opportunities
- Technological advancements
The prevalence of chronic diseases, advancements in drug discovery and development, and increased financing for R&D by both governmental and non-governmental organizations, along with advances in regenerative medicine, all contribute to the growth of the worldwide tissue banking market. In addition, biotech start-ups are creating biobanks that are fuelling the market's expansion even more. For instance, Orig3n, is working on building the most diverse biobank, harnessing the power of induced pluripotent stem cell technology for accelerating regenerative medicine.
Restraints/Challenges
- High cost
On the other hand, the high cost associated with this market will obstruct the growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the tissue banking market.
This tissue banking market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue banking market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Tissue Banking Market
Globally, the coronavirus disease (COVID-19) pandemic has resulted in a number of fatalities. Because of this, scientists rely on tissue banks to gather tissue samples, comprehend cellular responses and the biological effects of infection, and find new therapeutic interventions and prevention methods. In addition, the demand for tissue banking in drug discovery is increasing as more novel diseases are being diagnosed.
Global Tissue Banking Market Scope
The tissue banking market is segmented on the basis of product, tissue type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Equipment
- Cryopreservation Equipment
- Thawing Equipment
- Quality Control Equipment
- Others
- Media and Consumables
Tissue Type
- Heart Valves
- Cornea
- Brain and Spinal Cord
- Bone and Skin
Application
- Therapeutic
- Cosmetic
- Research and Development
- Drug Discovery
End-User
- Biobanks
- Hospitals and Clinics
Research and Academic Institutes
Others
Tissue Banking Market Regional Analysis/Insights
The tissue banking market is analyzed and market size insights and trends are provided by country, product, tissue type and application as referenced above.
The countries covered in the tissue banking market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tissue banking market owing to the strong foothold of healthcare infrastructure and the vivid number of patients.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and the growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Tissue Banking Market Share Analysis
The tissue banking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue banking market.
Some of the major players operating in the tissue banking market are:
- Thermo Fisher Scientific Inc. (U.S.)
- Sigma-Aldrich Co. (U.S.)
- BioLifeSolutions (U.S.)
- Lifeline Scientific (U.S.)
- BioCision, Cesca Therapeutics, Inc. (U.S.)
- core dynamics GmbH (U.S.)
- Custom Biogenic Systems (U.S.)
- Atlanta Biologics Pvt. Ltd. (U.S.)
- Taylor-Wharton (U.S.)
- Panasonic Holdings Corporation (Japan)
- QIAGEN (Germany)
- VWR International, LLC (U.S.)
- Danaher (U.S.)
- Tecan Trading AG (Switzerland)
- Brooks Automation, Inc. (U.S.)
SKU-